Hui J Shen, Age 95Fremont, CA

Hui Shen Phones & Addresses

Fremont, CA

Santa Clara, CA

1212 Nuuanu Ave, Honolulu, HI 96817

1212 Nuuanu Ave #3303, Honolulu, HI 96817

1212 Nuuanu Ave APT 3603, Honolulu, HI 96817

1255 Nuuanu Ave, Honolulu, HI 96817

1255 Nuuanu Ave #2811, Honolulu, HI 96817

1255 Nuuanu Ave #E E 1510, Honolulu, HI 96817

1010 Bishop St #1188, Honolulu, HI 96813

1188 Bishop St, Honolulu, HI 96813

1188 Bishop St #1010, Honolulu, HI 96813

421 Olohana St #2203, Honolulu, HI 96815

1020 Kaluanui Rd, Honolulu, HI 96825

1422 Miloiki St, Honolulu, HI 96825

3430 Otter Ct, Hayward, CA 94542

Castro Valley, CA

Arcadia, CA

Show more

Mentions for Hui J Shen

Career records & work history

Lawyers & Attorneys

Hui Shen Photo 1

Hui Shen - Lawyer

Office:
Steptoe & Johnson LLP
Specialties:
Clean Energy Technology, Intellectual Property, Patent: Nanotechnologies
ISLN:
922023621
University:
Huazhong University of Science & Technology, B.S., 1998; Huazhong University of Science & Technology, B.S., 1998; Huazhong University of Science & Technology, M.S., 2001; Huazhong University of Science & Technology, M.S., 2001; University of Virginia, Ph.D., 2008

Medicine Doctors

Hui Shen Photo 2

Hui Wang Shen

Specialties:
Psychiatry
Education:
National Defense Medical Center (1953)

License Records

Hui Wang Shen

Address:
Hayward, CA 94542
Licenses:
License #: MD034963L - Expired
Category: Medicine
Type: Medical Physician and Surgeon

Hui Shen resumes & CV records

Resumes

Hui Shen Photo 38

Hui Shen

Location:
United States

Publications & IP owners

Us Patents

Semi-Solid Delivery Vehicle And Pharmaceutical Compositions For Delivery Of Granisetron

US Patent:
8252304, Aug 28, 2012
Filed:
Sep 22, 2009
Appl. No.:
12/564881
Inventors:
Steven Y. Ng - San Francisco CA, US
Hui Rong Shen - Fremont CA, US
Jorge Heller - Ashland OR, US
Assignee:
A. P. Pharma, Inc. - Redwood City CA
International Classification:
A61K 31/435
A61K 31/439
A61K 31/53
A61K 47/30
C07D 319/04
US Classification:
424426, 424486, 424422, 424425, 514279, 514337, 514338, 514339, 5147723, 549335
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Methods Of Treating Emesis Utilizing Semi-Solid Delivery Pharmaceutical Compositions Comprising Granisetron

US Patent:
8252305, Aug 28, 2012
Filed:
Oct 24, 2011
Appl. No.:
13/279938
Inventors:
Steven Y. Ng - San Francisco CA, US
Hui Rong Shen - Fremont CA, US
Jorge Heller - Ashland OR, US
Assignee:
A.P. Pharma - Redwood City CA
International Classification:
A61K 31/439
A61K 31/435
A61K 31/46
A61K 31/416
A61K 47/30
A61P 1/08
C07D 319/04
US Classification:
424426, 424422, 424425, 424486, 514279, 514337, 514338, 514339, 5147723, 5147727, 549335
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Process For Preparing A Semi-Solid Delivery Vehicle Comprising Granisetron

US Patent:
8252306, Aug 28, 2012
Filed:
Oct 24, 2011
Appl. No.:
13/279949
Inventors:
Steven Y. Ng - San Francsico CA, US
Hui Rong Shen - Fremont CA, US
Jorge Heller - Ashland OR, US
Assignee:
A.P. Pharma, Inc. - Redwood City CA
International Classification:
A61K 31/439
A61K 31/435
A61K 31/46
A61K 31/416
A61K 47/30
A61P 1/08
C07D 319/04
US Classification:
424426, 424422, 424425, 424486, 514279, 514337, 514338, 514339, 5147723, 5147727, 549335
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Semi-Solid Delivery Vehicle And Pharmaceutical Compositions

US Patent:
2005004, Feb 24, 2005
Filed:
Sep 28, 2004
Appl. No.:
10/953841
Inventors:
Steven Ng - San Francisco CA, US
Hui Shen - Fremont CA, US
Jorge Heller - Woodside CA, US
Assignee:
A.P. PHARMA, INC. - Redwood City CA
International Classification:
A61K031/765
US Classification:
424078300
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Genome-Scale Analysis Of Aberrant Dna Methylation In Colorectal Cancer

US Patent:
2013006, Mar 14, 2013
Filed:
Jun 1, 2012
Appl. No.:
13/486988
Inventors:
TOSHINORI HINOUE - ALHAMBRA CA, US
HUI SHEN - SAN GABRIEL CA, US
DANIEL J. WEISENBERGER - LOS ANGELES CA, US
PETER W. LAIRD - SOUTH PASADENA CA, US
Assignee:
UNIVERSITY OF SOUTHERN CALIFORNIA - LOS ANGELES CA
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Particular aspects provide methods and compositions (e.g., gene marker panels) having substantial utility for at least one of diagnosis, identification and classification of colorectal cancer (CRC) (e.g., tumors) relating to distinctive DNA methylation-based subgroups of CRC including CpG island methylator phenotype (CIMP) groups (e.g., CIMP-H and CIMP-L) and non-CIMP groups. Exemplary marker panels include: B3GAT2, FOXL2, KCNK13, RAB31 and SLIT1 (CIMP marker panel); and FAM78A, FSTL1, KCNC1, MYOCD, and SLC6A4 (CIMP-H marker panel). Further aspects relate to genetic mutations, and other epigenetic markers relating to said CRC subgroups that can be used in combination with the gene marker panels for at least one of diagnosis, identification and classification of colorectal cancer (CRC) (e.g., tumors) relating to distinctive CIMP and non-CIMP groups.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.